Pilot Study to Assess the Efficacy of Aspirin to Improve Immunological Features of Ovarian Tumors

  • STATUS
    Not Recruiting
  • End date
    Mar 15, 2025
  • participants needed
    100
  • sponsor
    H. Lee Moffitt Cancer Center and Research Institute
Updated on 20 October 2022
ct scan
aspirin
platelet count
measurable disease
carcinoma
metastasis
neutrophil count
cancer chemotherapy
fallopian tube
taxane
carcinosarcoma
peritoneal carcinoma
tumor debulking
interval debulking surgery

Summary

The purpose of the study is to evaluate the effectiveness of aspirin with neoadjuvant chemotherapy for decreasing markers of immune suppression in the tumor at interval debulking surgery, in women with diagnosed ovarian, fallopian tube, or peritoneal carcinoma

Details
Condition Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
Treatment Placebo, Aspirin 325mg
Clinical Study IdentifierNCT05080946
SponsorH. Lee Moffitt Cancer Center and Research Institute
Last Modified on20 October 2022

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note